{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T21:30:56Z","timestamp":1772832656190,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100022840","name":"Serum Institute of India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022840","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jpba.2023.115679","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T02:27:45Z","timestamp":1692757665000},"page":"115679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Method development and validation of unbound saccharide content (serogroup A, C, Y, W, X) in novel pentavalent meningococcal polysaccharide conjugate vaccine with two different carrier proteins"],"prefix":"10.1016","volume":"236","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2458-767X","authenticated-orcid":false,"given":"Sameer","family":"Kale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swapnil","family":"Phugare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil Kumar","family":"Goel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Gairola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2023.115679_bib1","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/S0140-6736(07)61016-2","article-title":"Epidemic meningitis, meningococcaemia, and Neisseria meningitidis","volume":"369","author":"Stephens","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jpba.2023.115679_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2014.03.020","article-title":"Development of four sandwich ELISAs for quantitation of capsular polysaccharides from Neisseria meningitidis serogroups A, C, W and Y in multivalent vaccines","author":"Reyes","year":"2014","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jpba.2023.115679_bib3","first-page":"619","article-title":"Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger","volume":"80","author":"Boisier","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jpba.2023.115679_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2013.08.001","article-title":"Meningococcal X polysaccharide quantification by high-performance anion-exchange chromatography using synthetic N-acetylglucosamine-4-phosphate as standard","author":"Micoli","year":"2013","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jpba.2023.115679_bib5","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.biologicals.2013.12.001","article-title":"Process development and immunogenicity studies on a serogroup \u2018X\u2019 Meningococcal polysaccharide conjugate vaccine","volume":"42","author":"Chilukuri","year":"2014","journal-title":"Biologicals"},{"key":"10.1016\/j.jpba.2023.115679_bib6","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1016\/j.vaccine.2017.03.066","article-title":"Quality, immunogenicity and stability of meningococcal serogroup ACWY-CRM197, DT and TT glycoconjugate vaccines","volume":"35","author":"Beresford","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.jpba.2023.115679_bib7","first-page":"259","article-title":"Quantification of free polysaccharide in meningococcal polysaccharide-diphtheria toxoid conjugate vaccines","volume":"103","author":"Lei","year":"2000","journal-title":"Dev. Biol."},{"issue":"44","key":"10.1016\/j.jpba.2023.115679_bib8","doi-asserted-by":"crossref","first-page":"39875","DOI":"10.1021\/acsomega.2c04013","article-title":"Development of a new solid-phase extraction base method for free saccharide content estimation of meningococcal conjugate vaccines","volume":"7","author":"Ricco","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.jpba.2023.115679_bib9","doi-asserted-by":"crossref","first-page":"7815","DOI":"10.1016\/j.vaccine.2020.10.017","article-title":"Quantitation of novel pentavalent meningococcal polysaccharide conjugate vaccine (Men A-TT, Men C-CRM, Men Y-CRM, Men W-CRM, Men X-TT) using sandwich ELISA","volume":"38","author":"Phugare","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jpba.2023.115679_bib10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.biologicals.2013.03.003","article-title":"Serogroup quantitation of multivalent polysaccharide and polysaccharide conjugate meningococcal vaccines from China","volume":"41","author":"Cook","year":"2013","journal-title":"Biologicals"},{"issue":"36","key":"10.1016\/j.jpba.2023.115679_bib11","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1016\/j.vaccine.2013.05.098","article-title":"Quantitation of serogroups in multivalent polysaccharide-based meningococcal vaccines: optimization of hydrolysis conditions and chromatographic methods","volume":"31","author":"Cook","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jpba.2023.115679_bib12","first-page":"259","article-title":"Quantification of free polysaccharide in meningococcal polysaccharide-diphtheria toxoid conjugate vaccines","volume":"103","author":"Lei","year":"2000","journal-title":"Dev. Biol."},{"key":"10.1016\/j.jpba.2023.115679_bib13","first-page":"1","article-title":"Report of a WHO study group","author":"Cerebrospinal meningitis control","year":"1976","journal-title":"World Health Organ. Tech. Rep. Ser."},{"key":"10.1016\/j.jpba.2023.115679_bib14","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1128\/IAI.70.7.3707-3713.2002","article-title":"Effect of O acetylation of Neisseria meningitidis serogroup A capsular polysaccharide on development of functional immune responses","volume":"70","author":"Berry","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jpba.2023.115679_bib15","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0264-410X(00)00261-9","article-title":"Assessment of the stability and immunogenicity of meningococcal oligosaccharide C-CRM197 conjugate vaccines","volume":"19","author":"Ho","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.jpba.2023.115679_bib16","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1016\/S0264-410X(02)00342-0","article-title":"Physico-chemical and immunological examination of the thermal stability of tetanus toxoid conjugate vaccines","volume":"20","author":"Ho","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.jpba.2023.115679_bib17","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1016\/j.vaccine.2013.04.070","article-title":"Single priming dose of meningococcal group C conjugate vaccine (NeisVac-C) in infants","volume":"31","author":"Poellabauer","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jpba.2023.115679_bib18","first-page":"586","article-title":"Analysis of human serum immunoglobulin G against O-acetyl-positive and O-acetyl-negative serogroup W135 meningococcal capsular polysaccharide","volume":"12","author":"Giardina","year":"2005","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.jpba.2023.115679_bib19","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.4161\/hv.29696","article-title":"A physico-chemical assessment of the thermal stability of pneumococcal conjugate vaccine components","volume":"10","author":"Gao","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jpba.2023.115679_bib20","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/S0021-9258(19)41784-5","article-title":"Structural determination of the sialic acid polysaccharide antigens of Neisseria meningitidis serogroups B and C with carbon 13 nuclear magnetic resonance","volume":"250","author":"Bhattacharjee","year":"1975","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpba.2023.115679_bib21","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3390\/pathogens10080928","article-title":"Evaluation of critical quality attributes of a pentavalent (A, C, Y, W, X) meningococcal conjugate vaccine for global use","volume":"10","author":"Bolgiano","year":"2021","journal-title":"Pathogens"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170852300448X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170852300448X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:29:36Z","timestamp":1760002176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073170852300448X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":21,"alternative-id":["S073170852300448X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115679","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Method development and validation of unbound saccharide content (serogroup A, C, Y, W, X) in novel pentavalent meningococcal polysaccharide conjugate vaccine with two different carrier proteins","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115679","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115679"}}